Financial statements Polaris Laboratories Europe

Balance sheet of Polaris Laboratories Europe

Company age:
Age:
12 y. 16 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of POLARIS LABORATORIES EUROPE

Year
2019
2020
2021
2022
2023
Total assets 4 324 084,40 4 196 651,38 6 273 471,09 6 123 782,87 4 800 932,99
A. Fixed assets 367 267,73 324 530,49 669 639,47 541 400,93 527 567,64
B. Current assets 3 956 816,67 3 872 120,89 5 603 831,62 5 582 381,94 4 273 365,35
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 4 324 084,40 4 196 651,38 6 273 471,09 6 123 782,87 4 800 932,99
A. Equity -2 468 322,74 -1 747 740,96 -409 029,37 691 439,06 772 523,67
B. Liabilities and provisions for liabilities 6 792 407,14 5 944 392,34 6 682 500,46 5 432 343,81 4 028 409,32
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 6 756 604,17 5 905 165,14 6 527 334,26 5 338 716,28 3 853 036,83
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.